-

Shareholder Alert: Robbins LLP Announces HP Inc. (HPQ) Sued for Misleading Shareholders

SAN DIEGO & PALO ALTO, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of HP Inc. (NASDAQ: HPQ) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 23, 2017 and October 3, 2019. HP provides personal computing and other access devices, printing products, and related technologies and services.

If you suffered a loss as a result of HP's misconduct, click here.

HP Inc. (HPQ) Accused of Misleading Shareholders

According to the complaint, on June 21, 2016, HP announced a one-time investment of $450 million to buy back supplies from its channel partners to better align supplies inventory levels with demand. Consequently, HP adopted a new approach centered on a "four-box model," assuring investors it would improve managing and aligning to demand and avert the problems that necessitated the $450 million buy-back. HP continued to emphasize its confidence in the four-box model's predictability and the revenue growth experienced by it supplies business. However, on February 27, 2019, HP reported disappointing total supplies revenue for first quarter 2019, revealing that its four-box model lacked telemetry data to make reliable market share assumptions. HP later revealed it had used telemetry data for its other segments for years, indicating the Company knew the value of telemetry data and nevertheless, recklessly relied on the four-box model. Finally, on October 3, 2019, HP announced that it was moving away from using the four-box model to a model that de-emphasized supplies revenue and would be cutting up to 16% of its global workforce as part of the restructuring. On this news, HP's stock price fell nearly 10% to close at $16.64 per share.

HP Inc. (HPQ) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:HPQ

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...
Back to Newsroom